Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2

Journal of Neuro-Oncology

Volumn 64, Issue 1, 2003, Pages 155-160

  Lesniak, Maciej S ^a   Tyler, Betty M ^a   Pardoll, Drew M ^a   Brem, Henry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumors; Histopathology; Immunohistochemistry; Immunotherapy; Interleukins; Xenogenic cell line

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BIOMEDICAL ENGINEERING; BRAIN CANCER; BRAIN TISSUE; BRAIN TUMOR; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CELL AGGREGATION; CELL LINE; CELL MEDIATED CYTOTOXICITY; CENTRAL NERVOUS SYSTEM TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DNA VECTOR; DRUG MEGADOSE; DRUG TOLERABILITY; ENDOTHELIUM CELL; EXPERIMENTAL NEOPLASM; FEASIBILITY STUDY; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LONG TERM CARE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; RAT; SURVIVAL TIME; T LYMPHOCYTE; TISSUE NECROSIS; TUMOR GROWTH; WILD TYPE;

EID: 0043065266     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024987321527     Document Type: Conference Paper

References (29)

1. Black PM: Brain tumors - Part I. N Engl J Med 324: 1471-1476, 1991
2. Black PM: Brain tumors - Part II. N Engl J Med 324: 1555-1564, 1991
3. Kornblith PL and Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1-17, 1988
4. Glick RP, Lichtor, T, Kim TS, Ilangovan S, Cohen EP: Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce anti-tumor immunity to a murine glioma in vivo. Neurosurgery 36: 548-555, 1995
5. Glick RP, Lichtor T, De Zoeten E, Deshmukh P, Cohen EP: Prolongation of survival of mice with glioma treated with semiallogeneic fibrolasts secreting interleukin-2. Neurosurgery 45: 867-874, 1999
6. Lichtor T, Glick RP, Tarlock K, Moffett S, Mouw E, Cohen EP: Application of interleukin 2-secreting syngeneic/allogeneic fibrolasts in the treatment of primary and metastatic brain tumors. Cancer Gene Ther 9: 464-469, 2002
7. Deshmukh P, Glick RP, Lichtor T, Moser R, Cohen EP: Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice. J Neurosurg 94: 287-292, 2001
8. Hanes J, Sills A, Zhao Z, Suh KW, Tyler B, DiMeco F, Brat DJ, Choti MA, Leong KW, Pardoll DM, Brem H: Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharm Res 18: 899-906, 2001
9. Lesniak M, Sampath P, Viglione MP, Tyler B, Brem H: Comparative analysis of paracrine immunotherapy in experimental brain tumors. Neurosurgical Focus 9(6): 4, 2000
10. Thompson RC, Pardoll DM, Jaffee E, Tyler B, Brem H: Systemic and paracrine cytokine therapy using transduced tumor cells are synergistic in treating incracranical tumors. J Immunother 19: 405-413, 1997
11. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539-3543, 1993
12. Kaplan EL, Meier, P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1987
13. Pakzaban P, Isacson O: Neural xenotransplantation: Reconstruction of neuronal circuitry species barriers. Neuroscience 62: 989-1001, 1994
14. Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, Penn R, Starr P, VanHorne C, Kott HS, Dempsey PK, Fischman AJ, Raineri R, Manhart C, Dinsmore J, Isacson O: Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results. Cell Transplant 9: 273-278, 2000
15. Kordower JH: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332: 1118-1124, 1995
16. Nagatsu T, Ichinose H: GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: Their relations to dystonia and parkinsonism Neurochem Res 21: 245-250, 1996
17. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O: Short- and long-term survival and function of unilateral striatal dopamingeric grafts in Parkinson's disease. Ann Neurol 42: 95-107, 1997
18. Klassen H, Lund RD: Anatomical and behavioral correlates of a xenograft-mediated papillary reflex. Exp Neurol 102: 102-108, 1988
19. Klassen H, Lund RD: Parameters of retinal graft-mediated responses are related to underlying target innervation. Brain Res 533: 181-191, 1990
20. Hantraye P, Riche D, Maziere M, Isacson O: Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc Natl Acad Sci USA 89: 4187-4191, 1992
21. Johnston P, Nam M, Hossain MA, Indurti RR, Mankowski JL, Wilson MA, Laterrra J: Delivery of human fibroblast growth factor-1 gene to brain by modified rat brain endothelial cells. J Neurochem 67: 1643-1652, 1996
22. Galpern WG, Burns LH, Deacon TW, Dinsmore J, Isacson O: Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp Neurol 140: 1-13, 1996
23. Mayer E, Dunnett SB, Pelliterri R, Fawcett JW: Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. Neuroscience 56: 379-388, 1993
24. Nakao N, Frodel EM, Widner H, Carlson E, Eggerding FA, Epstein CJ, Brundin P: Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med 1: 226-231, 1995
25. Ahmed R, Morrison LA, Knipe DM: Persistence of viruses. In: Fields BN, Howley PM (eds) Fields Virology. 3rd edn, Lippincott-Raven Publishers, Philadelphia, PA, 1996, pp 221-241
26. Coffin JM: Retroviridae: The viruses and their replication. In: Fields BN, Howley PM (eds) Fields Virology. 3rd edn, Lippincott-Raven Publishers, Philadelphia, PA, 1996, pp 1767-1847
27. Degrave W, Simons G, Devos R, Plaetinck G, Remaut E, Tavernier J, Fiers W: Cloning and structure of a mouse interleukin-2 chromosomal gene. Mol Biol Rep 11: 57-61, 1986
28. Hank JA, Surfus J, Gan J, Albertini M, Lindstrom M, Schiller JH, Hotton KM, Khorsan M, Sondel PM: Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations. Clin Cancer Res 5: 281-289, 1999
29. Bleackley RC, Barr PJ, Havele C, Hooton J, Ng J, Meier M, Merryweather JP, Gibbs C, Paetkau V: Biologic activities of recombinant human interleukin-2 on murine lymphocytes. Lymphokine Res 4: 117-131, 1985